Biofisica

Atlanta, United States Founded: 2000 • Age: 26 yrs
Develops electrical stimulation devices to promote wound healing.

About Biofisica

Biofisica was a Healthcare company based in Atlanta (United States) founded in 2000 by Rafael Andino. It develops electrical stimulation devices to promote wound healing. It operates on a B2B model. Biofisica has raised $7.3 million across 3 funding rounds from investors including Novartis, ATDC and Unilever Ventures. Its chief executive, as recorded, is Rafael Andino. The company is recorded as dissolved. Its focus areas include Medical Devices, Wound Care and Electrical Stimulation. Its competitors include Celleration, Vomaris Innovations and BioElectronics Corporation; 2 of its 3 listed competitors have raised funding.

Company details

Biofisica, based in Atlanta, focuses on providing healthcare solutions, developing medical devices, wound care, and electrical stimulation. Develops electrical stimulation devices to promote wound healing. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Atlanta, United States
  • Founders Rafael Andino
  • Sectors
    Healthcare
  • Website biofisica.com
Operational Areas
Key Metrics
  • Total Equity Funding
    $7.3M (USD)

    in 3 rounds

  • Latest Funding Round
    $2.3M (USD), Series A

    Apr 2008

  • Investors
    Novartis

    & 3 more

Funding Insights of Biofisica

Biofisica has successfully raised a total of $7.3M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.3 million completed in April 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $7.3M
  • Total Rounds 3
  • Last Round Series A β€” $2.3M
  • First Round $5M

    (Oct 2006)

  • Investors Count 4

All 3 funding rounds of Biofisica with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2008$2.3MSeries A–Unilever Ventures
Aug 2007$2MDebt – Venture––
Oct 2006$5MSeries A–Unilever Ventures
Valuation history

4 investors in total: 4 institutional.

Investors in Biofisica

Biofisica has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Novartis, ATDC and Unilever Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
ATDC is recognized as a leading technology startup incubator.
1980atdc.orgAtlanta, United States
Corporate-backed venture capital firm focused on consumer tech and multiple sectors
unileverventures.comLondon, United Kingdom
Venture debt and equity financing is offered to US startups.
leaderventures.comPalo Alto, United States
R&D focused on manufacturing of drugs for multiple therapeutic areas
1996novartis.comBasel, Switzerland
Premium access

Investor details for Biofisica

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Biofisica

1 people are tracked at Biofisica (1 in leadership).

NameRoleGroup
Rafael Andino
Founder, ex-CEOLeadership
Premium access

Complete people profiles for Biofisica

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Biofisica

3 dated milestones of Biofisica across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Biofisica is founded.
  2. Funding First funding round of $5.0M.
  3. Funding Latest funding round, Series A, of $2.3M.

Competitors of Biofisica

Biofisica has 3 listed competitors in our database, 2 of them funded. They include Celleration, Vomaris Innovations and BioElectronics Corporation.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
celleration.com1999Eden Prairie, United States$70.57M43
Ultrasound technology for wound healing is developed and marketed.
vomaris.com2004Phoenix, United States$16.2M
Bio-mimicking microcurrent technology is applied to wound healing.
bielcorp.com2000Frederick, United States
Medical devices are developed to reduce pain and inflammation.
Premium access

Detailed competitors of Biofisica

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Wound Care

3 companies that operate in the same segment as Biofisica (Wound Care) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Nanotech-based wound care products are developed and provided.
2010Madison, Wisconsin, United StatesUSD 22.7 M35
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
1985Marietta, Georgia, United StatesUSD 418.63 M837
Developer of hemostatic products for wound care
2010New York, New York, United StatesUSD 113.35 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biofisica

Premium access

Complete news archive for Biofisica

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biofisica

Biofisica was founded in 2000 and raised its 1st funding round 6 years after it was founded.

Biofisica is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.

Rafael Andino is the CEO of Biofisica, as recorded in our data. They have also founded this company.

Biofisica is a funded company, having raised a total of $7.3M across 3 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Oct 2006.

Biofisica, based in Atlanta, focuses on providing healthcare solutions, developing medical devices, wound care, and electrical stimulation. Develops electrical stimulation devices to promote wound healing. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Biofisica's top competitors include BioElectronics Corporation, Celleration and Vomaris Innovations.

Biofisica has 4 investors. Key investors include Novartis, ATDC, Unilever Ventures, and Leader Ventures.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available